Property:BGT In Clinical Trial For(P303)
From BiomedGT
BGT_In_Clinical_Trial_For(P303)
Lexical
Concept Code: P303
Preferred Name: In_Clinical_Trial_For
Coding Scheme: BGT (08.11a )
Synonym: In_Clinical_Trial_For (PT) (Source: NCI)
Definition: Indicates a disease for which this drug is currently being tested as a potential treatment. (Source: NCI)
URI: http://ncicb.nci.nih.gov/xml/owl/EVS/BiomedGT.owl:P303
Properties
Semantic_Type: Conceptual Entity
NCI_META_CUI: CL337319
Associations
Facts about BGT In Clinical Trial For(P303)RDF feed
| BGT NCI META CUI(P208) | CL337319 +info.pngNCI META CUI lookup |
| BGT Semantic Type(P106) | Conceptual Entity +info.pngSemantic Type lookup |
| BGT Synonym(P104) | In_Clinical_Trial_For + |
| DCTerms hasVersion(hasVersion) | BGT/Versions/08.11a + |
| Has typeThis property is a special property in this wiki. | StringThis type is among the standard datatypes of this wiki. |
| LexWiki Concept Code | P303 + |
| LexWiki Definition | Indicates a disease for which this drug is currently being tested as a potential treatment. (Source: NCI) |
| LexWiki Preferred Name | In_Clinical_Trial_For + |
| LexWiki URI | http://ncicb.nci.nih.gov/xml/owl/EVS/BiomedGT.owl:P303 + |
| SKOS inScheme(inScheme) | BGT + |
Pages using the property “BGT In Clinical Trial For(P303)”
Showing 24 pages using this property.
B | |
|---|---|
| Category:BGT 111InIbritumomab Tiuxetan(B2752) + | B-cell lymphoma; recurrent or refractory CD20-positive lymphoma + |
| Category:BGT 111InMonoclonal Antibody B3(B2788) + | Tumor Targeting + |
| Category:BGT 111InMonoclonal Antibody BrE 3(B2781) + | Metastatic Breast Cancer. + |
| Category:BGT 111InMonoclonal Antibody Lym 1(B2391) + | recurrent or refractory non-Hodgkins lymphoma. + |
| Category:BGT 111InMonoclonal Antibody M170(B2706) + | Hormone-Refractory Prostate Cancer. + |
| Category:BGT 111InMonoclonal Antibody MN14(B2392) + | Advanced Ovarian Epithelial Cancer. + |
| Category:BGT 11CAcetate(B38885) + | Hepatocellular carcinoma, detection + |
| Category:BGT 11CMethionine(B1707) + | Prostate cancer, imaging + |
| Category:BGT 123IMonoclonal Antibody 81C6(B2662) + | Malignant Glioma. + |
| Category:BGT 125IDeoxyuridine(B2130) + | Breast Cancer; Colorectal Cancer and Lymphoma + |
| Category:BGT 131IAntiferritin Immunoglobulin(B2530) + | non-metastatic non-resectable primary hepatoma. + |
| Category:BGT 131ILipiodol(B2869) + | Curatively Resected Hepatocellular Carcinoma. + |
| Category:BGT 131IMetaiodobenzylguanidine(B1143) + | Neuroblastoma; pheochromocytoma + |
| Category:BGT 131IMonoclonal Antibody 3F8(B2604) + | GD2 Positive Leptomeningeal Neoplasms and Medulloblastoma. + |
| Category:BGT 131IMonoclonal Antibody 81C6(B2661) + | Malignant Primary Brain Tumors; Primary and Metastatic Brain Tumors. + |
| Category:BGT 131IMonoclonal Antibody A33(B2650) + | Advanced Colorectal Carcinoma. + |
| Category:BGT 131IMonoclonal Antibody BC8(B2700) + | Advanced Myeloid Leukemia; Acute Myelogenous Leukemia in First Remission; Advanced Acute Lymphocytic Leukemia; Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome. + |
| Category:BGT 131IMonoclonal Antibody CC49(B2870) + | Colorectal Cancer and Gastrointestinal Adenocarcinoma. + |
| Category:BGT 131IMonoclonal Antibody F19(B2688) + | Colorectal Cancer with Patients Scheduled for Resection. + |
| Category:BGT 131IMonoclonal Antibody G250(B2622) + | Advanced Renal-Cell Carcinoma. + |
| Category:BGT 131IMonoclonal Antibody Lym 1(B2276) + | Aggressive B-cell Lymphoma; Previously Treated Diffuse Large Cell Lymphoma; Intermediate or High Grade Recurrent or Refractory B-cell Non-Hodgkins Lymphoma. + |
| Category:BGT 131IMonoclonal Antibody muJ591(B2777) + | Progressive Androgen-Independent Prostate Cancer. + |
| Category:BGT 131IMonoclonal Antibody TNT 1B(B2396) + | glioblastoma multiforme and anaplastic astrocytoma. + |
| Category:BGT 131ITositumomab(B2617) + | Mantle cell lymphoma; Non-Hodgkins lymphoma + |
